Columbia neurologist Denise Chou, MD, explains a new breakthrough in headache medicine: the first targeted preventive therapy for migraine.
The discovery that pain receptors continue to function within nerves may lead to more effective pain medications with fewer side effects.
Researchers report that CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome.
Certain women with preeclampsia are more likely to have a pregnancy-related stroke, finds a new study led by Columbia neurologists.
Writing in NEJM, Columbia ophthalmologists say a form of Vitamin B3 may be able to stop the progression of glaucoma by protecting the eye's neurons.
Joseph Shivers, MD'17, planned an unforgettable marriage proposal to Sarah Meister in a place with special meaning for his medical education.